Placebo Sufentanil NanoTab PCA System
Sponsors
Talphera, Inc
Conditions
Post Operative PainPost-Operative Pain
Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery
CompletedNCT01539642
Start: 2012-02-29End: 2013-02-28Updated: 2015-10-20
Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery
CompletedNCT01660763
Start: 2012-08-31End: 2013-05-31Updated: 2015-10-20